Gain Therapeutics, Inc.

SEC 4 · Filed

0001104659-26-035403Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Mar 24, 2026

Grant, award or other acquisition by Mack Gene

Security
Employee Stock Option (right to buy)
Code
A
Shares
200,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-03-24",
  "direction": "A",
  "exercise_price": "1.86",
  "expiration": "2036-03-24",
  "footnotes": {
    "F1": "The shares underlying the option shall vest as to 25% on March 24, 2027, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person\u0027s continuous service through each such vesting date."
  },
  "owners": [
    {
      "cik": "0001737979",
      "name": "Mack Gene",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO, President"
    }
  ],
  "ownership": "D",
  "post_shares": "200000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Employee Stock Option (right to buy)",
  "shares": "200000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "200000"
}